Wang Mengchen, Fan Shuai, Wang Zixu, Ren Jixiang
Changchun University of Chinese Medicine, Changchun, China.
Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
Front Neurosci. 2025 Jun 13;19:1572086. doi: 10.3389/fnins.2025.1572086. eCollection 2025.
Insomnia is a prevalent and debilitating sleep disorder affecting approximately one-third of the global population, with 10-15% of individuals progressing to chronic insomnia. Acoustic stimulation, a promising non-pharmacological treatment, has gained significant attention due to its ability to improve sleep quality without the adverse effects of drugs. This study aims to evaluate the clinical efficacy of acoustic stimulation for treating insomnia through a systematic review and meta-analysis.
We conducted a systematic search of both Chinese and English literature from PubMed, Embase, Web of Science, Cochrane, and Clinical Trials databases to identify randomized controlled trials (RCTs) evaluating acoustic stimulation for insomnia. The search period ranged from the establishment of the database to January 1, 2025. Two independent evaluators assessed study quality and extracted relevant data. Statistical analyses were conducted using RevMan 5.4 and Stata 18.0 software.
This meta-analysis includes 8 studies involving 419 patients. The results showed that acoustic stimulation significantly improved insomnia severity as evidenced by PSQI and ISI scores. Despite no significant improvement in sleep efficiency (SE) and Total sleep time (TST), acoustic stimulation notably increased total sleep time and alleviated insomnia symptoms. The test group demonstrated significant improvements compared to the control group, with the following outcomes: PSQI score [MD = -2.68, 95% CI (-3.35, -2.01), < 0.00001] and ISI score [MD = -2.26, 95% CI (-4.09, -0.43), = 0.02].
Acoustic stimulation is an effective and safe treatment for insomnia, offering significant improvements in sleep quality, severity, and overall health, with minimal side effects. It presents a promising alternative to traditional pharmacological treatments, especially for long-term use, and its clinical application has broad prospects. Future studies should focus on expanding sample sizes, exploring various stimulation methods, and considering individual patient characteristics for more detailed analyses.
https://www.crd.york.ac.uk/PROSPERO/view/CRD42025632371, identifier CRD42025632371.
失眠是一种普遍且使人衰弱的睡眠障碍,影响着全球约三分之一的人口,其中10% - 15%的人会发展为慢性失眠。声刺激作为一种有前景的非药物治疗方法,因其能够改善睡眠质量且无药物不良反应而受到广泛关注。本研究旨在通过系统评价和荟萃分析评估声刺激治疗失眠的临床疗效。
我们对来自PubMed、Embase、Web of Science、Cochrane和临床试验数据库的中英文文献进行了系统检索,以确定评估声刺激治疗失眠的随机对照试验(RCT)。检索期从数据库建立至2025年1月1日。两名独立评估者评估研究质量并提取相关数据。使用RevMan 5.4和Stata 18.0软件进行统计分析。
该荟萃分析纳入了8项研究,涉及419名患者。结果表明,声刺激显著改善了失眠严重程度,这由PSQI和ISI评分证明。尽管睡眠效率(SE)和总睡眠时间(TST)没有显著改善,但声刺激显著增加了总睡眠时间并减轻了失眠症状。与对照组相比,试验组有显著改善,结果如下:PSQI评分[MD = -2.68,95% CI(-3.35,-2.01),< 0.00001]和ISI评分[MD = -2.26,95% CI(-4.09,-0.43),= 0.02]。
声刺激是一种有效且安全的失眠治疗方法,能显著改善睡眠质量、严重程度和整体健康状况,副作用极小。它是传统药物治疗的一种有前景的替代方法,尤其适用于长期使用,其临床应用前景广阔。未来的研究应侧重于扩大样本量、探索各种刺激方法,并考虑个体患者特征以进行更详细的分析。
https://www.crd.york.ac.uk/PROSPERO/view/CRD42025632371,标识符CRD42025632371。